Health in Code specializes in genetic testing and provides solutions for the prevention, diagnosis, prognosis, and treatment of hereditary diseases. The company offers a variety of genetic tests and bioinformatics software.

Health in Code

AIQ Global provides technology-enabled services for managing late-stage cancer, utilizing TRAQinform IQ technology to assist oncologists and clinicians in adjusting therapies.

AIQ Global

Archer provides next generation sequencing (NGS) assay solutions for solid tumors, blood cancers, immune profiling, and genetic disease research. The company offers customizable assay content and a user-friendly bioinformatics platform.

Archer

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

Metric
Company Name	Health in Code	AIQ Global	Archer	Guardant Health, Inc.
Symbol				GH
MSH ID	COM:HEALTHINCODE	COM:AIQ-SOLUTIONS	COM:ARCHERDX	COM:GUARDANTHEALTH
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Genetics	Medical Technology	Biotechnology	Medical - Diagnostics & Research
Country	ES	US	US	US
Stage			Post-IPO
Employee Count				1.77K
Website	healthincode.com	aiq-solutions.com	archerdx.com	guardanthealth.com
LinkedIn				guardanthealth
Founders

Metric
Market Cap		3.38B
Enterprise Value
Monthly Web Traffic	86.10K
Web Traffic Growth	-0.13
Valuation
Raised Capital	230M

Metric
Revenue				563.95M
Revenue (LTM)
Revenue (NTM)
Gross Profit				336.90M
EBITDA				-519.63M
Operating Income				-562.51M
Net Income				-479.45M
EPS				-4.28
Diluted EPS				-4.28
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.85
Operating Profit Margin				-0.79
EBITDA Margin				-0.92
Net Profit Margin				-0.76
Return on Equity				-2.46
Return on Assets				-0.27
Return on Capital Employed				-0.36

COM:HEALTHINCODE

Health in Code

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-5.81
P/B Ratio				11.00
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				7.32
EV Multiple				-3.51

Metric
Days Sales Outstanding				60.50
Days Payables Outstanding				134.21
Days Inventory Outstanding				271.12
Operating Cycle				328.58
Cash Conversion Cycle				148.03
Asset Turnover				0.40

Metric
Operating Cash Flow				-324.98M
Free Cash Flow				-345.46M
Cash Flow to Debt				-0.14
Operating Cash Flow/Sales				-0.29
Free Cash Flow Yield				-0.14

Metric
Cash & Equivalents				1.13B
Accounts Receivable				8.38M
Inventory				61.95M
Goodwill				3.29M
Debt to Capitalization				1.00
Debt to Assets				0.76
Current Ratio				5.94
Quick Ratio				6.11

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.17
R&D to Revenue				0.72
SG&A to Revenue				0.29